Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Red cell transfusion in infants and children: Selection of blood products

INTRODUCTION

Transfusions of red blood cells (RBCs) are given to children in a wide variety of clinical settings. This includes children with anemia due to congenital or acquired disease, or blood loss from trauma or surgery. Once the decision to transfuse RBCs has been made, the most appropriate RBC product must be chosen. Donated whole blood used for transfusion is modified in several ways that remove varying proportions of non-red cell components, thereby allowing selection of RBC products based upon clinical needs.

This topic will review the different RBC products and indications for their use in infants and children who require RBC transfusions. The indications, methods of administration, and complications of RBC transfusion in infants and children are discussed separately. (See "Red blood cell transfusion in infants and children: Indications" and "Red blood cell transfusion in infants and children: Administration and complications".)

RED BLOOD CELL PRODUCTS

Whole blood — The use of whole blood in pediatric patients is limited. Whole blood is most often used for patients undergoing major cardiac surgery. Whole blood has also been given for exchange transfusion in newborns for severe hemolytic disease or hyperbilirubinemia, and in patients undergoing massive transfusion; however, reconstituted blood (packed red cells and fresh frozen plasma) is more commonly used for these indications [1]. Some clinicians have advocated whole blood when patients are placed on extracorporeal membrane oxygenation (ECMO) [1].

Fresh whole blood (generally less than 48 hours old) has been reported to improve hemostasis in infants undergoing cardiac surgery [2,3]. This was shown in a randomized trial of 61 infants less than one month of age who underwent cardiac surgery and cardiopulmonary bypass [4]. Patients who received blood reconstituted with fresh red blood cells (RBCs), platelets, and plasma from a single donor had less postoperative chest tube volume loss, lower need for inotropic support, shorter ventilatory time, and shorter hospital stay, as compared to those who received packed RBCs. It should be noted, however, that the control group in this study used relatively old packed RBCs (14 ± 8 days old).

On the other hand, a randomized trial of 96 infants requiring cardiopulmonary bypass found no advantage, and perhaps disadvantages, in the use of fresh whole blood compared to reconstituted packed RBCs and fresh frozen plasma for priming the pump circuit [5]. In addition, fresh whole blood increased perioperative fluid accumulation and the length of stay in the intensive care unit. Thus, use of fresh whole blood for pediatric cardiac surgery remains controversial. In addition, whole blood is not readily available in most areas of the United States.

                   

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2014. | This topic last updated: Apr 10, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Roseff SD, Luban NL, Manno CS. Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 2002; 42:1398.
  2. Manno CS, Hedberg KW, Kim HC, et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood 1991; 77:930.
  3. Kwiatkowski JL, Manno CS. Blood transfusion support in pediatric cardiovascular surgery. Transfus Sci 1999; 21:63.
  4. Gruenwald CE, McCrindle BW, Crawford-Lean L, et al. Reconstituted fresh whole blood improves clinical outcomes compared with stored component blood therapy for neonates undergoing cardiopulmonary bypass for cardiac surgery: a randomized controlled trial. J Thorac Cardiovasc Surg 2008; 136:1442.
  5. Mou SS, Giroir BP, Molitor-Kirsch EA, et al. Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants. N Engl J Med 2004; 351:1635.
  6. Menitove JE. Standards for blood banks and transfusion services, 21st ed, American Association of Blood Banks, Bethesda 2002.
  7. Hayashi Y, Sawa Y, Nishimura M, et al. Clinical evaluation of leukocyte-depleted blood cardioplegia for pediatric open heart operation. Ann Thorac Surg 2000; 69:1914.
  8. Derleth DP. Use of white cell-reduced red cells for transfusion through peripheral arterial lines. Transfusion 1994; 34:86.
  9. Fergusson D, Hébert PC, Barrington KJ, Shapiro SH. Effectiveness of WBC reduction in neonates: what is the evidence of benefit? Transfusion 2002; 42:159.
  10. Przepiorka D, LeParc GF, Werch J, Lichtiger B. Prevention of transfusion-associated cytomegalovirus infection. Practice parameter. American Society of Clinical Pathologists. Am J Clin Pathol 1996; 106:163.
  11. Laupacis A, Brown J, Costello B, et al. Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement. Transfusion 2001; 41:560.
  12. Nichols WG, Price TH, Gooley T, et al. Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood 2003; 101:4195.
  13. Benson JW, Bodden SJ, Tobin JO. Cytomegalovirus and blood transfusion in neonates. Arch Dis Child 1979; 54:538.
  14. Adler SP, Chandrika T, Lawrence L, Baggett J. Cytomegalovirus infections in neonates acquired by blood transfusions. Pediatr Infect Dis 1983; 2:114.
  15. Lamberson HV, Dock NL. Prevention of transfusion-transmitted cytomegalovirus infection. Transfusion 1992; 32:196.
  16. Logan S, Barbara J, Kovar I. Cytomegalovirus screened blood for neonatal intensive care units. Arch Dis Child 1988; 63:753.
  17. Miller WJ, McCullough J, Balfour HH Jr, et al. Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening. Bone Marrow Transplant 1991; 7:227.
  18. Roback JD. CMV and blood transfusions. Rev Med Virol 2002; 12:211.
  19. Pelszynski MM, Moroff G, Luban NL, et al. Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease. Blood 1994; 83:1683.
  20. Funkhouser AW, Vogelsang G, Zehnbauer B, et al. Graft versus host disease after blood transfusions in a premature infant. Pediatrics 1991; 87:247.
  21. Strauss RG. Blood banking and transfusion issues in perinatal medicine. In: Hematologic problems of the neonate, Christensen RD (Ed), WB Saunders, Philadelphia 2000. p.405.
  22. Strauss RG. Practical issues in neonatal transfusion practice. Am J Clin Pathol 1997; 107:S57.
  23. Strauss RG, Sacher RA, Blazina JF, et al. Commentary on small-volume red cell transfusions for neonatal patients. Transfusion 1990; 30:565.
  24. Brown KA, Bissonnette B, MacDonald M, Poon AO. Hyperkalaemia during massive blood transfusion in paediatric craniofacial surgery. Can J Anaesth 1990; 37:401.
  25. Carvalho B, Quiney NF. 'Near-miss' hyperkalaemic cardiac arrest associated with rapid blood transfusion. Anaesthesia 1999; 54:1094.
  26. Hall TL, Barnes A, Miller JR, et al. Neonatal mortality following transfusion of red cells with high plasma potassium levels. Transfusion 1993; 33:606.
  27. Horsey PJ. Hyperkalaemia associated with transfusion of plasma reduced blood. Anaesthesia 2000; 55:294.
  28. Baz EM, Kanazi GE, Mahfouz RA, Obeid MY. An unusual case of hyperkalaemia-induced cardiac arrest in a paediatric patient during transfusion of a 'fresh' 6-day-old blood unit. Transfus Med 2002; 12:383.
  29. Strauss RG. Routinely washing irradiated red cells before transfusion seems unwarranted. Transfusion 1990; 30:675.
  30. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. Second of two parts--blood conservation. N Engl J Med 1999; 340:525.
  31. Silvergleid AJ. Safety and effectiveness of predeposit autologous transfusions in preteen and adolescent children. JAMA 1987; 257:3403.
  32. Novak RW. Autologous blood transfusion in a pediatric population. Safety and efficacy. Clin Pediatr (Phila) 1988; 27:184.
  33. Murto KT, Splinter WM. Perioperative autologous blood donation in children. Transfus Sci 1999; 21:41.
  34. Anand N, Idio FG Jr, Remer S, Hoppenfeld S. The effects of perioperative blood salvage and autologous blood donation on transfusion requirements in scoliosis surgery. J Spinal Disord 1998; 11:532.
  35. Murray DJ, Forbes RB, Titone MB, Weinstein SL. Transfusion management in pediatric and adolescent scoliosis surgery. Efficacy of autologous blood. Spine (Phila Pa 1976) 1997; 22:2735.
  36. Floss AM, Strauss RG, Goeken N, Knox L. Multiple transfusion fail to provoke antibodies against blood cell antigens in human infants. Transfusion 1986; 26:419.
  37. Diab YA, Wong EC, Luban NL. Massive transfusion in children and neonates. Br J Haematol 2013; 161:15.
  38. Lee AC, Reduque LL, Luban NL, et al. Transfusion-associated hyperkalemic cardiac arrest in pediatric patients receiving massive transfusion. Transfusion 2014; 54:244.
  39. Win N, Doughty H, Telfer P, et al. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion 2001; 41:323.